Arlington Capital eyes both add-ons and organic growth for CBSET
'The faster you can get a lifesaving product to market in a compliant and cost-effective way, the better,' says Arlington's Matthew Altman.
1 October 2025•3 mins read
'The faster you can get a lifesaving product to market in a compliant and cost-effective way, the better,' says Arlington's Matthew Altman.
